BRIEF—SaudiVax inks deal with Minapharm and MiGenTra

Saudi Arabia’s SaudiVax is partnering with Egyptian biotech services firm Minapharm Pharmaceuticals and Germany’s MiGenTra.

The companies have signed a memorandum of understanding, focused on advancing healthcare solutions and meeting growing demand for biologics in the Middle East.

The goal of the project is for the companies to jointly pursue potential business opportunities in Saudi Arabia and surrounding countries.

In a statement, SaudiVax said the partnership would “leverage the companies’ strengths, matching Minapharm’s and MiGenTra’s cutting-edge development and manufacturing technologies and translational experience of high-quality affordable bio-engineered products with SaudiVax’s industrial capabilities and commercial reach in the region.”